Drug-Eluting Stents Market Share, Size & Segmentation 2022-27

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2027, exhibiting at a CAGR of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

Polymer Based Coating
Polymer Free Coating

Breakup by Drug:

Sirolimus
Paclitaxel
Zotarolimus
Everolimus
Biolimus
Others

Breakup by Stent Platform:

Stainless-steel
Cobalt-Chromium
Platinum-Chromium
Nitinol
Others

Breakup by Generation:

1st Generation
2nd Generation
3rd Generation
4th Generation

Breakup by Application:

Coronary Artery Disease
Peripheral Artery Disease

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2021
Historical Period	2016-2021
Forecast Period	2022-2027
Units	US$ Billion
Segment Coverage	Coating, Drug, Stent Platform, Generation, Application, End User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the global drug-eluting stents market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug-eluting stents market?
What are the key regional markets?
What is the breakup of the market based on the coating?
What is the breakup of the market based on the drug?
What is the breakup of the market based on the stent platform?
What is the breakup of the market based on the generation?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug-eluting stents market and who are the key players?
What is the degree of competition in the industry?

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Electrosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Blood Glucose Test Strips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Medical Lasers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Digital Patient Monitoring Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

10% Free customization

Purchase Options

Single User License $ 2499
Five User License $ 3499
Corporate License $ 4499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Change Language
Select Language

Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

Drug-Eluting Stents Market Trends:

Key Market Segmentation:

Competitive Landscape:

Report Coverage:

Key Questions Answered in This Report:

Need more help?

Related Report

Social Links

Change Language Select Language

Medical Devices